These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 34292566)
1. Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the "miraculous" sodium-glucose co-transporter-2 inhibitors? Author's reply. Terlecki M; Wojciechowska W; Klocek M; Kania M; Małecki M; Grodzicki T; Rajzer M Kardiol Pol; 2021; 79(9):1050-1051. PubMed ID: 34292566 [No Abstract] [Full Text] [Related]
2. Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the "miraculous" sodium-glucose co-transporter-2 inhibitors? Patoulias D; Papadopoulos C; Kassimis G; Doumas M Kardiol Pol; 2021; 79(9):1048-1049. PubMed ID: 34292565 [No Abstract] [Full Text] [Related]
3. Effects of long-term use of sodium-glucose co-transporter-2 inhibitors on plasma volume status in patients with type 2 diabetes mellitus: Sub-analysis of a prospective, observational study during the COVID-19 pandemic. Patoulias D; Papadopoulos C; Zografou I; Katsimardou A; Imprialos K; Stavropoulos K; Tranidou A; Karagiannis A; Doumas M Kardiol Pol; 2022; 80(1):80-82. PubMed ID: 34783355 [No Abstract] [Full Text] [Related]
4. Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs. Imprialos KP; Stavropoulos K; Doumas M Cardiovasc Hematol Disord Drug Targets; 2018; 18(2):83-85. PubMed ID: 30009694 [No Abstract] [Full Text] [Related]
5. Author's Reply to Kuss and Rathmann's Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data". Gamble JM; Alkabbani W Drug Saf; 2023 May; 46(5):513-514. PubMed ID: 37060424 [No Abstract] [Full Text] [Related]
6. Sodium-glucose co-transporter-2 inhibitors and protection from cardiovascular death: Is it all about heart failure? Caruso I; Cignarelli A; Laviola L; Giorgino F Diabetes Obes Metab; 2021 Sep; 23(9):2194-2196. PubMed ID: 34033214 [No Abstract] [Full Text] [Related]
7. Reply to 'Epicardial adipose tissue: does it mediate the cardio-protective effects of sodium-glucose co-transporter 2 inhibitors in subjects with heart failure?' Letter regarding the article 'Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure'. De Biase N; Del Punta L; Pugliese NR Eur J Heart Fail; 2022 Feb; 24(2):401. PubMed ID: 34985799 [No Abstract] [Full Text] [Related]
8. Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable? Koufakis T; Metallidis S; Zebekakis P; Ajjan RA; Kotsa K J Diabetes Sci Technol; 2020 Jul; 14(4):745-747. PubMed ID: 32486846 [No Abstract] [Full Text] [Related]
9. The Multiple Effects of SGLT2 Inhibitors Suggest Potential Benefit in COVID-19 Patients. Soni S; Dyck JRB Can J Cardiol; 2020 Oct; 36(10):1691.e3. PubMed ID: 32717278 [No Abstract] [Full Text] [Related]
10. SGLT-2 inhibitors for COVID-19 - A miracle waiting to happen or just another beat around the bush? Chatterjee S Prim Care Diabetes; 2020 Oct; 14(5):564-565. PubMed ID: 32493609 [No Abstract] [Full Text] [Related]
11. Acute hyperglycemic crises with sodium-glucose co-transporter-2 inhibitors across the cardiovascular and renal outcome trials: An anticipated fear? Patoulias D; Papadopoulos C; Doumas M Endocrinol Diabetes Nutr (Engl Ed); 2022; 69(7):547-549. PubMed ID: 36084991 [No Abstract] [Full Text] [Related]
12. Sodium-glucose co-transporter-2 inhibitors, cardiovascular outcomes and the impact of gender: Class effect or statistical play of chance? Patoulias D; Papadopoulos C; Doumas M Diabetes Metab Syndr; 2020; 14(4):347. PubMed ID: 32305776 [No Abstract] [Full Text] [Related]
13. Treatment of heart failure: the dawn of the era of sodium-glucose co-transporter-2 inhibitors. Crea F Eur Heart J; 2020 Sep; 41(36):3379-3383. PubMed ID: 33216881 [No Abstract] [Full Text] [Related]